SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 240 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,592,523 | +5.4% | 44,646 | +0.0% | 0.26% | +12.7% |
| Q3 2022 | $1,511,000 | -20.8% | 44,634 | -32.3% | 0.23% | +36.3% |
| Q2 2022 | $1,907,000 | +271.0% | 65,943 | +131.0% | 0.17% | +309.8% |
| Q1 2020 | $514,000 | +44.0% | 28,550 | +89.9% | 0.04% | +86.4% |
| Q4 2019 | $357,000 | -82.0% | 15,038 | -84.6% | 0.02% | -86.0% |
| Q2 2016 | $1,988,000 | +33.6% | 97,600 | 0.0% | 0.16% | +68.8% |
| Q1 2016 | $1,488,000 | -2.6% | 97,600 | -14.2% | 0.09% | -55.5% |
| Q4 2015 | $1,528,000 | +11.6% | 113,700 | +16.5% | 0.21% | +574.2% |
| Q3 2015 | $1,369,000 | -17.9% | 97,600 | -0.6% | 0.03% | -29.5% |
| Q2 2015 | $1,667,000 | +189.9% | 98,200 | +106.6% | 0.04% | +214.3% |
| Q1 2015 | $575,000 | +197.9% | 47,541 | +120.7% | 0.01% | +180.0% |
| Q1 2014 | $193,000 | – | 21,539 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 335,000 | $8,934,000 | 13.38% |
| ASHFORD CAPITAL MANAGEMENT INC | 1,016,665 | $27,114,000 | 2.46% |
| Bruce & Co., Inc. | 402,105 | $10,724,000 | 2.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 297,500 | $7,934,000 | 1.91% |
| ARMISTICE CAPITAL, LLC | 3,900,000 | $104,013,000 | 1.76% |
| Bridge City Capital, LLC | 108,884 | $2,904,000 | 1.32% |
| S&T BANK/PA | 316,098 | $8,430,000 | 1.31% |
| Kent Lake Capital LLC | 100,000 | $2,667,000 | 1.15% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 331,140 | $8,832,000 | 1.02% |
| Prairiewood Capital, LLC | 45,297 | $1,208,000 | 0.99% |